Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Desta

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2013
Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validationL Weng, D Ziliak, H K Im, et al.
Clinical Pharmacology and Therapeutics|May 17, 2012
Compartment-specific gene regulation of the CAR inducer efavirenz in vivoH E Meyer zu Schwabedissen, S Oswald, C Bresser, et al.
Clinical Pharmacology and Therapeutics|October 7, 2011
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and ageZ Desta, Y Kreutz, A T Nguyen, et al.
The Pharmacogenomics Journal|August 24, 2016
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancerD L Hertz, K M Kidwell, N J Seewald, et al.
The Pharmacogenomics Journal|May 8, 2009
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patientsJ M Rae, M J Sikora, N L Henry, et al.
Clinical Pharmacology and Therapeutics|August 24, 2007
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifenN I Ntukidem, A T Nguyen, V Stearns, et al.
Clinical Pharmacology and Therapeutics|February 3, 2012
Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteersS Oswald, H E Meyer zu Schwabedissen, A Nassif, et al.
The Pharmacogenomics Journal|August 22, 2012
Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomicsY Ji, J M Biernacka, S Hebbring, et al.
British Journal of Cancer|October 3, 2013
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effectsN L Henry, H-P Chan, J Dantzer, et al.
Clinical Pharmacology and Therapeutics|February 7, 2016
Implementation of a pharmacogenomics consult service to support the INGENIOUS trialM T Eadon, Z Desta, K D Levy, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2013
Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validationL Weng, D Ziliak, H K Im, et al.
Clinical Pharmacology and Therapeutics|May 17, 2012
Compartment-specific gene regulation of the CAR inducer efavirenz in vivoH E Meyer zu Schwabedissen, S Oswald, C Bresser, et al.
Clinical Pharmacology and Therapeutics|October 7, 2011
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and ageZ Desta, Y Kreutz, A T Nguyen, et al.
The Pharmacogenomics Journal|August 24, 2016
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancerD L Hertz, K M Kidwell, N J Seewald, et al.
The Pharmacogenomics Journal|May 8, 2009
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patientsJ M Rae, M J Sikora, N L Henry, et al.
Clinical Pharmacology and Therapeutics|August 24, 2007
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifenN I Ntukidem, A T Nguyen, V Stearns, et al.
Clinical Pharmacology and Therapeutics|February 3, 2012
Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteersS Oswald, H E Meyer zu Schwabedissen, A Nassif, et al.
The Pharmacogenomics Journal|August 22, 2012
Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomicsY Ji, J M Biernacka, S Hebbring, et al.
British Journal of Cancer|October 3, 2013
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effectsN L Henry, H-P Chan, J Dantzer, et al.
Clinical Pharmacology and Therapeutics|February 7, 2016
Implementation of a pharmacogenomics consult service to support the INGENIOUS trialM T Eadon, Z Desta, K D Levy, et al.
Pageof 4